These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 18621565

  • 1. The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration.
    Grisanti S, Tatar O.
    Prog Retin Eye Res; 2008 Jul; 27(4):372-90. PubMed ID: 18621565
    [Abstract] [Full Text] [Related]

  • 2. Role of vascular endothelial growth factor in ocular angiogenesis.
    Shams N, Ianchulev T.
    Ophthalmol Clin North Am; 2006 Sep; 19(3):335-44. PubMed ID: 16935208
    [Abstract] [Full Text] [Related]

  • 3. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.
    Funk M, Karl D, Georgopoulos M, Benesch T, Sacu S, Polak K, Zlabinger GJ, Schmidt-Erfurth U.
    Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A tag-single nucleotide polymorphisms approach to the vascular endothelial growth factor-A gene in age-related macular degeneration.
    Richardson AJ, Islam FM, Guymer RH, Cain M, Baird PN.
    Mol Vis; 2007 Nov 26; 13():2148-52. PubMed ID: 18079689
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Surgical treatment of age-related macular degeneration.
    Skaf AR, Mahmoud T.
    Semin Ophthalmol; 2011 May 26; 26(3):181-91. PubMed ID: 21609231
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cardiovascular risk and antiangiogenic therapy for age-related macular degeneration.
    Tuñón J, Ruiz-Moreno JM, Martín-Ventura JL, Blanco-Colio LM, Lorenzo O, Egido J.
    Surv Ophthalmol; 2009 May 26; 54(3):339-48. PubMed ID: 19422962
    [Abstract] [Full Text] [Related]

  • 12. Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration.
    Ciulla TA, Rosenfeld PJ.
    Curr Opin Ophthalmol; 2009 May 26; 20(3):166-74. PubMed ID: 19381089
    [Abstract] [Full Text] [Related]

  • 13. Expression of vasohibin, an antiangiogenic factor, in human choroidal neovascular membranes.
    Wakusawa R, Abe T, Sato H, Yoshida M, Kunikata H, Sato Y, Nishida K.
    Am J Ophthalmol; 2008 Aug 26; 146(2):235-243. PubMed ID: 18486097
    [Abstract] [Full Text] [Related]

  • 14. New approaches in the management of choroidal neovascular membrane in age-related macular degeneration.
    Verma L, Das T, Binder S, Heriot WJ, Kirchhof B, Venkatesh P, Krebs I, Stolba U, Jahn C, Feichtinger H, Kellner L, Krugluger H, Pawelka I, Frohner U, Kruger A, Li W, Tewari HK.
    Indian J Ophthalmol; 2000 Dec 26; 48(4):263-78. PubMed ID: 11340884
    [Abstract] [Full Text] [Related]

  • 15. Complement Factor P in choroidal neovascular membranes of patients with age-related macular degeneration.
    Wolf-Schnurrbusch UE, Stuck AK, Hess R, Wolf S, Enzmann V.
    Retina; 2009 Dec 26; 29(7):966-73. PubMed ID: 19584655
    [Abstract] [Full Text] [Related]

  • 16. Neuropilin-1 expression by endothelial cells and retinal pigment epithelial cells in choroidal neovascular membranes.
    Lim JI, Spee C, Hangai M, Rocha J, Ying HS, Ryan SJ, Hinton DR.
    Am J Ophthalmol; 2005 Dec 26; 140(6):1044-1050. PubMed ID: 16376649
    [Abstract] [Full Text] [Related]

  • 17. Management of neovascular age-related macular degeneration.
    Schmidt-Erfurth UM, Pruente C.
    Prog Retin Eye Res; 2007 Jul 26; 26(4):437-51. PubMed ID: 17512238
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor.
    Economou MA, Wu J, Vasilcanu D, Rosengren L, All-Ericsson C, van der Ploeg I, Menu E, Girnita L, Axelson M, Larsson O, Seregard S, Kvanta A.
    Invest Ophthalmol Vis Sci; 2008 Jun 26; 49(6):2620-6. PubMed ID: 18515591
    [Abstract] [Full Text] [Related]

  • 19. [Macular translocation - a therapeutic approach for neovascular macular degeneration in the era of anti-VEGF therapy?].
    Ziemssen F, Gelisken F.
    Klin Monbl Augenheilkd; 2009 Jan 26; 226(1):31-7. PubMed ID: 19173161
    [Abstract] [Full Text] [Related]

  • 20. Immunological factors in the pathogenesis and treatment of age-related macular degeneration.
    Kijlstra A, La Heij E, Hendrikse F.
    Ocul Immunol Inflamm; 2005 Feb 26; 13(1):3-11. PubMed ID: 15804763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.